Ukrainian Soldiers: Fighting the Secret War of Addiction

The battle for Ukraine is being fought on two fronts: the physical trenches of the east and an invisible, internal war against substance abuse. While the world focuses on drone strikes and territorial gains, a burgeoning public health crisis is unfolding within the ranks of the Ukrainian Armed Forces, where the trauma of high-intensity conflict is driving soldiers toward a dangerous reliance on opioids, amphetamines, and synthetic stimulants.

The Deep Dive: The Anatomy of a Wartime Relapse

The trajectory of addiction in a conflict zone often follows a predictable, tragic pattern: physical injury leads to prescription painkillers, which, under the crushing weight of combat stress, evolve into a dependency on illicit opioids. For many Ukrainian soldiers, the drug of choice depends on the operational phase. Stimulants like amphetamines are utilized to maintain vigilance during grueling stretches of duty, while “downers” and alcohol are used during rotations to blunt intrusive memories and manage severe anxiety.

This phenomenon is not unique to Ukraine but is amplified by the scale of this conflict. Historically, modern warfare has always shadowed a rise in substance use disorders (SUD). However, the current crisis is exacerbated by the accessibility of synthetic drugs—often ordered via post or shared through encrypted apps—and a military infrastructure that, until recently, lacked the capacity to track mental health casualties. When a soldier uses chemicals to “forget everything they’ve seen,” they aren’t treating a medical condition; they are masking a psychological wound that, if left untreated, evolves into severe, treatment-resistant PTSD.

The role of rehabilitation clinics, such as the one in Kyiv led by Oleh Olishevskiy, represents a critical pivot. By integrating group therapy, physical activity, and potentially cutting-edge treatments like ketamine-assisted therapy, these facilities are attempting to treat the trauma and the addiction as a single, intertwined pathology. Yet, the effectiveness of these interventions is currently hampered by the reality of the war: the desperate need for boots on the ground often overrides the medical necessity for full recovery.

The Forward Look: The Looming Post-War Challenge

As the conflict persists, the medical community is bracing for a “second wave” of casualties—not from shrapnel, but from the long-term effects of addiction and psychological collapse. We can expect several critical developments in the coming years:

1. A Public Health Integration Crisis: When the fighting eventually ceases, Ukraine will face the monumental task of reintegrating hundreds of thousands of veterans into civilian life. If the current shortage of rehabilitation facilities persists, the country risks a domestic addiction epidemic similar to the opioid crisis seen in the U.S. following the wars in Iraq and Afghanistan.

2. The Normalization of Psychedelic Medicine: The mention of ketamine trials suggests that Ukraine may become a primary testing ground for rapid-acting antidepressants and PTSD treatments. Given the scale of the trauma, the Ukrainian medical establishment may accelerate the adoption of psychedelic-assisted therapies faster than Western counterparts.

3. Policy Shifts in Mobilization: The revelation that mobilization officers are knowingly enlisting individuals with existing addictions suggests a critical vulnerability in force readiness. Expect a future tightening of medical screenings as the military realizes that substance-dependent soldiers are not only a liability to themselves but a risk to operational security and unit cohesion.